Spotlight on Metastatic Breast Cancer
In 2024 alone, approximately 297,790 women and 2,800 men will be diagnosed with breast cancer, and it’s estimated that up to 30 percent of patients will develop metastatic disease.
That’s why Spotlight on Metastatic Breast Cancer takes an in-depth look at the driving forces and innovations behind the latest diagnostic and treatment advances, featuring expert insights from leading clinicians and researchers dedicated to the fight against this disease.
Episodes 1-15 of 16
Treatment Selection Strategies for Metastatic Breast Cancer Patients
Project Oncology®Treatment Selection Strategies for Metastatic Breast Cancer Patients
Detecting Metastatic Breast Cancer: The Role of Scans and Emerging Blood Tests
Project Oncology®Detecting Metastatic Breast Cancer: The Role of Scans and Emerging Blood Tests
Emerging Metastatic Breast Cancer Therapies: From CDK Inhibitors to SERDs and Beyond
Project Oncology®Emerging Metastatic Breast Cancer Therapies: From CDK Inhibitors to SERDs and Beyond
Breast Cancer Care Advancements: Using AI to Detect Lymph Node Metastasis
Project Oncology®Breast Cancer Care Advancements: Using AI to Detect Lymph Node Metastasis
When Breast Cancer Spreads to the Brain: Diagnosis and Treatment Strategies
Project Oncology®When Breast Cancer Spreads to the Brain: Diagnosis and Treatment Strategies
Approaches to Utilizing Bone-targeting Therapies in mBC
Project Oncology®Approaches to Utilizing Bone-targeting Therapies in mBC
The Role of PARP Inhibitors in Metastatic Breast Cancer
Project Oncology®The Role of PARP Inhibitors in Metastatic Breast Cancer
Advances in Early-Stage Breast Cancer Treatment: A Recap of the NATALEE Trial
Project Oncology®Advances in Early-Stage Breast Cancer Treatment: A Recap of the NATALEE Trial
Diving into the Efficacy & Tolerability of mBC Treatment
Project Oncology®Diving into the Efficacy & Tolerability of mBC Treatment
Exploring Efficacy & Overall Survival in the TROPiCS-02 Trial
Project Oncology®Exploring Efficacy & Overall Survival in the TROPiCS-02 Trial
Evaluating Landmark Clinical Data for HER2-low Breast Cancer
Project Oncology®Evaluating Landmark Clinical Data for HER2-low Breast Cancer
Evaluating a Treatment for HER2-Positive Metastatic Breast Cancer
Project Oncology®Evaluating a Treatment for HER2-Positive Metastatic Breast Cancer
Updates on Breast Cancer Treatment: Exploring CDK4/6 Inhibitors & Endocrine Therapy
Project Oncology®Updates on Breast Cancer Treatment: Exploring CDK4/6 Inhibitors & Endocrine Therapy
The Emerging Role of Immunotherapy in Triple-Negative Breast Cancer
Project Oncology®The Emerging Role of Immunotherapy in Triple-Negative Breast Cancer
Treating Metastatic Breast Cancer: Where Are We Now?
Project Oncology®Treating Metastatic Breast Cancer: Where Are We Now?
